What is the ticker symbol for Otonomy?

Otonomy trades under the ticker OTIC on NASDAQ.

What sector does Otonomy operate in?

Otonomy is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OTIC in a portfolio?

PortView shows OTIC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Otonomy (OTIC) Stock Analysis

NASDAQHealthcareBiotechnology

$0.01-92.64%

1-year price historyRange $0.01 – $2.51

52-week range$0.01

$0.01$2.51

What Otonomy does

Otonomy, Inc., a biopharmaceutical firm established in 2008 and headquartered in San Diego, California, concentrates on pioneering treatments for neurotological disorders throughout the United States. Its robust pipeline includes several programs: OTO-313, a sustained-release formulation of the N-methyl-D-aspartate receptor antagonist gacyclidine, currently in Phase II clinical trials for addressing tinnitus; and OTO-413, a sustained-exposure brain-derived neurotrophic factor, which is undergoing Phase IIa studies to mend cochlear synaptopathy and alleviate speech-in-noise hearing difficulties. The company is also advancing OTO-510, an otoprotectant designed to prevent hearing loss induced by cisplatin, along with OTO-825, a gene therapy aimed at congenital hearing loss. Additionally, OTO-6XX is being developed to stimulate hair cell repair and regeneration for severe hearing impairment. Otonomy holds licensing agreements with the University of California and DURECT Corporation, and has a strategic alliance with Applied Genetic Technologies Corporation focused on gene therapy solutions for congenital hearing loss.

Key metrics

Market cap

P/E (TTM)

-0.14

EPS (TTM)

$-0.06

Beta

1.57

Dividend yield

1294.12%

Revenue / share

$0.00

50-day avg

$0.11

200-day avg

$0.36

52-week high

$2.51

52-week low

$0.01

CEO

David M. Maggio

ETFs linked to OTIC

Broad-market and Healthcare sector ETFs an investor holding Otonomy is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OTIC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OTIC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Otonomy?: Otonomy trades under the ticker OTIC on NASDAQ.
Which exchange is OTIC listed on?: OTIC is listed on NASDAQ.
What sector does Otonomy operate in?: Otonomy is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OTIC in a portfolio?: PortView shows OTIC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.